figitumumab: Clinical Trials

7 trials of figitumumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 terminated, 1 withdrawn. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Terminated 3, Withdrawn 1
Phase 12Completed 2

Follow figitumumab: new trials by email Literature Review of figitumumab trials Research Report on figitumumab

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
figitumumab, Cisplatin (Or Carboplatin), Etoposide - Small Cell Lung Carcinoma
Phase 2TerminatedPfizer92010-04-012013-02-25
Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer
CP-751,871, Docetaxel - Breast Cancer
Phase 2WithdrawnPfizer2009-04-012015-05-04
A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma
CP-751,871 - Head and Neck Cancer
Phase 2TerminatedCliniques universitaires Saint-Luc- Université Catholique de Louvain372009-01-012016-04-20
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
CP-751,871 - Ewing's Sarcoma Family of Tumors
Phase 1 / Phase 2CompletedPfizer1382008-03-012015-10-28
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
CP-751,871, exemestane, Fulvestrant - Breast Neoplasms
Phase 2TerminatedPfizer2192007-02-012015-10-28
Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)
CP-751,871, docetaxel, prednisone - Prostatic Neoplasms
Phase 2CompletedPfizer2042006-05-012013-04-11
Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
CP-751,871, paclitaxel, carboplatin - Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2CompletedPfizer2822005-02-012013-10-30

Conditions studied

Breast Neoplasms (2)  ·  Breast Diseases (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)  ·  Recurrence (1)  ·  Small Cell Lung Carcinoma (1)

Sponsors

Pfizer (6)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)

Countries

Canada (5)  ·  United States (5)  ·  Spain (4)  ·  Italy (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Germany (2)  ·  Argentina (1)  ·  Australia (1)  ·  Chile (1)  ·  France (1)  ·  Hungary (1)  ·  Israel (1)  ·  Netherlands (1)

Top investigators

Jean-Pascal Machiels, MDPhD (1)

Results publications

PMID 22025154, PMID 24536060